{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:04:50Z","timestamp":1776121490755,"version":"3.50.1"},"reference-count":149,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["psy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.psychres.2014.10.028","type":"journal-article","created":{"date-parts":[[2014,11,16]],"date-time":"2014-11-16T20:53:31Z","timestamp":1416171211000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Ketamine and other potential glutamate antidepressants"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2906-3286","authenticated-orcid":false,"given":"Arpan","family":"Dutta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"McKie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F. William","family":"Deakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2014.10.028_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"aan het Rot","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/YCT.0b013e31824f8296","article-title":"Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting","volume":"28","author":"Abdallah","year":"2012","journal-title":"Journal of ECT"},{"key":"10.1016\/j.psychres.2014.10.028_bib3","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2014.14010067","article-title":"Glutamate Metabolism in Major Depressive Disorder","author":"Abdallah","year":"2014","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1177\/0269881110376695","article-title":"Lamotrigine: when and where does it act in affective disorders? A systematic review","volume":"25","author":"Amann","year":"2011","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuroscience.2010.04.035","article-title":"Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex","volume":"169","author":"Ampuero","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.psychres.2014.10.028_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archpsyc.57.3.270","article-title":"Attenuation of the neuropsychiatric effects of ketamine with lamotrigine","volume":"57","author":"Anand","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib7","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301312","article-title":"Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders","volume":"32","author":"Beneyto","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF00370302","article-title":"Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre","volume":"419","author":"Benoit","year":"1991","journal-title":"European Journal of Physiology"},{"key":"10.1016\/j.psychres.2014.10.028_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1017\/S1461145707007924","article-title":"Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients","volume":"11","author":"Bhagwagar","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib11","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1523\/JNEUROSCI.4262-04.2005","article-title":"Amantadine inhibits NMDA receptors by accelerating channel closure during channel block","volume":"25","author":"Blanpied","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.psychres.2014.10.028_bib12","first-page":"12","article-title":"Proton MR spectroscopy of the hippocampus at 3T in patients with unipolar major depressive disorder: correlates and predictors of treatment response","author":"Block","year":"2009","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib13","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/sj.npp.1301039","article-title":"Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice","volume":"31","author":"Boyce-Rustay","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02761776","article-title":"Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain","volume":"10","author":"Boyer","year":"1998","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.psychres.2014.10.028_bib15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/npp.2009.191","article-title":"Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole","volume":"35","author":"Brennan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib16","unstructured":"Burch, R.M., 2012. A phase 2, randomized, double blind, single intravenous dose study of GLYX-13, an NMDA receptor glycine site functional partial agonist, in subjects with Major Depressive Disorder with inadequate response to antidepressant medication. In: Proceedings of the ACNP 51st Annual Meeting, Hollywood, December 2012."},{"key":"10.1016\/j.psychres.2014.10.028_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group","volume":"60","author":"Calabrese","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.biopsych.2013.02.008","article-title":"Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study","volume":"73","author":"Carlson","year":"2013","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0253-7176.127258","article-title":"Acute antidepressant effects of intramuscular versus intravenous ketamine","volume":"36","author":"Chilukuri","year":"2014","journal-title":"Indian Journal of Psychological Medicine"},{"key":"10.1016\/j.psychres.2014.10.028_bib21","doi-asserted-by":"crossref","first-page":"15653","DOI":"10.1073\/pnas.0507901102","article-title":"Altered cortical glutamatergic and GABAergic signal transmission and glial involvement in depression","volume":"102","author":"Choudhary","year":"2005","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.psychres.2014.10.028_bib22","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1096\/fj.08-106450","article-title":"AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression","volume":"22","author":"Chourbaji","year":"2008","journal-title":"FASEB Journal"},{"key":"10.1016\/j.psychres.2014.10.028_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biopsych.2012.03.029","article-title":"Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression","volume":"72","author":"Cornwell","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1526-4637.2006.00101.x","article-title":"Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions","volume":"7","author":"Correll","year":"2006","journal-title":"Pain Medicine"},{"key":"10.1016\/j.psychres.2014.10.028_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00008877-200305000-00007","article-title":"Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine","volume":"14","author":"De Vry","year":"2003","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archgenpsychiatry.2007.37","article-title":"Glutamate and the neural basis of the subjective effects of ketamine","volume":"65","author":"Deakin","year":"2008","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1176\/appi.ajp.2011.11010128","article-title":"Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation","volume":"168","author":"Denk","year":"2011","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib28","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N-methyl-d-aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"Diazgranados","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-d-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1034\/j.1399-5618.2000.020110.x","article-title":"Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial","volume":"2","author":"Dietrich","year":"2000","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.psychres.2014.10.028_bib31","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.npp.1301178","article-title":"The anticonvulsants lamotrigine, riluzole and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders","volume":"32","author":"Du","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2012.05.042","article-title":"Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder","volume":"145","author":"Duncan","year":"2013","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.psychres.2014.10.028_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S1461145712000545","article-title":"Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder","volume":"16","author":"Duncan","year":"2013","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WNF.0b013e3180314ae7","article-title":"An open-label, flexible dose study of memantine in major depressive disorder","volume":"30","author":"Ferguson","year":"2007","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pnpbp.2008.10.005","article-title":"Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression","volume":"33","author":"Feyissa","year":"2009","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pnpbp.2009.11.018","article-title":"Elevated level of metabotropic glutamate receptor 2\/3 in the prefrontal cortex in major depression","volume":"34","author":"Feyissa","year":"2010","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.neuron.2014.01.027","article-title":"The genetics of major depression","volume":"81","author":"Flint","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2014.10.028_bib38","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00213-013-3378-0","volume":"231","author":"Fukumoto","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"194","author":"Geddes","year":"2009","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.psychres.2013.12.008","article-title":"Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder","volume":"215","author":"Ghasemi","year":"2014","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2014.10.028_bib41","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.biopsych.2010.11.031","article-title":"Dose- and exposure-response to ketamine in depression","volume":"70","author":"Glue","year":"2011","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.yct.0000263257.44539.23","article-title":"Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy","volume":"23","author":"Goforth","year":"2007","journal-title":"Journal of ECT"},{"key":"10.1016\/j.psychres.2014.10.028_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000026528","article-title":"Modulation of calcium and potassium currents by lamotrigine","volume":"38","author":"Grunze","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psychres.2014.10.028_bib44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1461145713001119","article-title":"Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression","volume":"17","author":"Haile","year":"2014","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Research Reviews"},{"key":"10.1016\/j.psychres.2014.10.028_bib46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00406-013-0399-y","article-title":"Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders","volume":"263","author":"Hashimoto","year":"2013","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.psychres.2014.10.028_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","article-title":"Reduced prefrontal glutamate\/glutamine and \u03b3-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy","volume":"64","author":"Hasler","year":"2007","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib48","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/bja\/77.4.441","article-title":"Ketamine: its mechanism(s) of action and unusual clinical uses","volume":"77","author":"Hirota","year":"1996","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.psychres.2014.10.028_bib49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00000542-199901000-00023","article-title":"Stereoselective interaction of ketamine with recombinant \u03bc, \u03ba and \u03b4 opiod receptors expressed in chinese hamster ovary cells","volume":"90","author":"Hirota","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.psychres.2014.10.028_bib50","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1073\/pnas.85.4.1307","article-title":"Block of N-methyl-d-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels","volume":"85","author":"Huettner","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.psychres.2014.10.028_bib51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/JCP.0b013e31825d70d6","article-title":"A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder","volume":"32","author":"Ibrahim","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib52","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/npp.2011.338","article-title":"Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study","volume":"37","author":"Ibrahim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib53","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2011.03.019","article-title":"Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression","volume":"35","author":"Ibrahim","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib54","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/jpm.2010.9808","article-title":"Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care","volume":"13","author":"Irwin","year":"2010","journal-title":"Journal of Palliative Medicine"},{"key":"10.1016\/j.psychres.2014.10.028_bib55","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/YCT.0b013e318283b7e9","article-title":"Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study","volume":"29","author":"Jarventausta","year":"2013","journal-title":"Journal of ECT"},{"key":"10.1016\/j.psychres.2014.10.028_bib56","first-page":"742","article-title":"NMDA receptors in clinical neurology: excitatory times ahead","volume":"7","author":"Kalia","year":"2008","journal-title":"Neurology"},{"issue":"Suppl.","key":"10.1016\/j.psychres.2014.10.028_bib58","first-page":"177S","article-title":"Glutamate receptors expression in postmortem brain from depressed patients","volume":"65","author":"Karolewicz","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/syn.10010","article-title":"NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans","volume":"43","author":"Kegeles","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.psychres.2014.10.028_bib60","first-page":"1186","article-title":"Ketamine: teaching an old drug new tricks","volume":"87","author":"Kohrs","year":"1998","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.psychres.2014.10.028_bib61","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00406-011-0205-7","article-title":"Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study","volume":"261","author":"Kranaster","year":"2011","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.psychres.2014.10.028_bib62","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00000539-200207000-00020","article-title":"Small-dose ketamine improves the postoperative state of depressed patients","volume":"95","author":"Kudoh","year":"2002","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.psychres.2014.10.028_bib63","doi-asserted-by":"crossref","first-page":"e39212","DOI":"10.1371\/journal.pone.0039212","article-title":"Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study","volume":"7","author":"Kurita","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2014.10.028_bib64","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.biopsych.2012.05.031","article-title":"Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients","volume":"72","author":"Laje","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib65","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","article-title":"A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder","volume":"76","author":"Lapidus","year":"2014","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib66","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1097\/00001756-200109170-00043","article-title":"Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses","volume":"12","author":"Law","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.psychres.2014.10.028_bib67","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1111\/j.1528-1157.1991.tb05882.x","article-title":"Neurochemical and behavioral aspects of lamotrigine","volume":"32","author":"Leach","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.psychres.2014.10.028_bib68","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.psychres.2014.10.028_bib69","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/15622970701420481","article-title":"Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression","volume":"10","author":"Liebrenz","year":"2009","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib70","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0006-8993(97)00255-2","article-title":"Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA in the rat medial prefrontal cortex","volume":"759","author":"Lindefors","year":"1997","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2014.10.028_bib71","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jad.2012.04.032","article-title":"Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial","volume":"142","author":"Loo","year":"2012","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.psychres.2014.10.028_bib72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2014.02.017","article-title":"Do the dissociative side effects of ketamine mediate its antidepressant effects?","volume":"159","author":"Luckenbaugh","year":"2014","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.psychres.2014.10.028_bib73","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1113\/jphysiol.1991.sp018396","article-title":"Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones","volume":"432","author":"MacDonald","year":"1991","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.psychres.2014.10.028_bib74","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharmthera.2009.02.010","article-title":"Ketamine and the next generation of antidepressants with a rapid onset of action","volume":"123","author":"Machado-Vieira","year":"2009","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.psychres.2014.10.028_bib75","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4088\/JCP.08m04659","article-title":"Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-d-aspartate antagonist","volume":"70","author":"Machado-Vieira","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib76","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of \u03b1-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib77","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0447.1998.tb10004.x","article-title":"Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity","volume":"97","author":"Maes","year":"1998","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.psychres.2014.10.028_bib78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S1461145709000169","article-title":"Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized placebo controlled continuation trial","volume":"13","author":"Mathew","year":"2010","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib79","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.mp.4002005","article-title":"Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten latency of antidepressant medication?","volume":"12","author":"Matrisciano","year":"2007","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib80","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"Mayberg","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2014.10.028_bib81","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s00213-005-2270-y","article-title":"Neuronal effects of acute citalopram detected by pharmacoMRI","volume":"180","author":"McKie","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib83","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0022-3565(24)37943-1","article-title":"Differences in degree of trapping of low-affinity uncompetitive N-methyl-d-aspartic acid receptor antagonists with similar kinetics of block","volume":"288","author":"Mealing","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.psychres.2014.10.028_bib84","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1176\/jnp.2010.22.4.442","article-title":"The use of a series of ketamine infusions in two patients with treatment-resistant depression","volume":"22","author":"Messer","year":"2010","journal-title":"Journal of Neuropsychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.psychres.2014.10.028_bib85","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2010.06.003","article-title":"Glial and glutamatergic markers in depression, alcoholism and their comorbidity","volume":"127","author":"Miguel-Hidalgo","year":"2010","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.psychres.2014.10.028_bib86","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2006.04.037","article-title":"Antidepressant-like effects of ceftriaxone in male C57BL\/6J mice","volume":"61","author":"Mineur","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib87","article-title":"d-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression","author":"Moaddel","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib88","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.psychres.2014.10.028_bib89","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0773.1993.tb01351.x","article-title":"Potential antidepressive properties of amantadine, memantine and bifemelane","volume":"72","author":"Moryl","year":"1993","journal-title":"Pharmacology and Toxicology"},{"key":"10.1016\/j.psychres.2014.10.028_bib90","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0002-9343(99)00316-2","article-title":"Efficacy of newer medications for treating depression in primary care patients","volume":"108","author":"Mulrow","year":"2000","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.psychres.2014.10.028_bib91","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib92","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib93","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(01)01089-5","article-title":"Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine","volume":"423","author":"Narita","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib94","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pscychresns.2009.05.003","article-title":"Normal metabolite levels in the dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel 1H spectroscopy study","volume":"174","author":"Nery","year":"2009","journal-title":"Neuroimaging"},{"key":"10.1016\/j.psychres.2014.10.028_bib95","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.4088\/JCP.13m08698","article-title":"Clinical predictors of ketamine response in treatment-resistant major depression","volume":"75","author":"Niciu","year":"2014","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib96","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1176\/ajp.2006.163.9.1519","article-title":"A comparison of lithium and T3 augmentation following two failed medication treatments for depression: a STAR\u204eD report","volume":"163","author":"Nierenberg","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib97","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1073\/pnas.95.5.2642","article-title":"Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-d-aspartate receptor-mediated calcium influx","volume":"95","author":"Nonaka","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.psychres.2014.10.028_bib98","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0014-2999(97)01589-6","article-title":"Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors","volume":"342","author":"Nowak","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2999(95)00585-4","article-title":"Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment","volume":"295","author":"Nowak","year":"1996","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neulet.2004.09.035","article-title":"The NR1 subunit of the glutamate\/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders","volume":"372","author":"Nudmamud-Thanoi","year":"2004","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.psychres.2014.10.028_bib101","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/YCT.0b013e3181c3b0aa","article-title":"Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia","volume":"26","author":"Okamoto","year":"2010","journal-title":"Journal of ECT"},{"key":"10.1016\/j.psychres.2014.10.028_bib102","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867043455594","article-title":"Trends in the development of new antidepressants. Is there a light at the end of the tunnel?","volume":"11","author":"Pacher","year":"2004","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.psychres.2014.10.028_bib103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-0029-1237375","article-title":"Oral administration of the NMDA receptor antagonists S-ketamine as add-on therapy of depression: a case series","volume":"43","author":"Paslakis","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib104","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/15622970701714370","article-title":"Comparison of racemic ketamine and S-ketamine in treatment resistant major depression: report of two cases","volume":"10","author":"Paul","year":"2009","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0033-1349861","article-title":"Vitamin B12 level may be related to the efficacy of single ketamine infusion in bipolar depression","volume":"46","author":"Permoda-Osip","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib106","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biopsych.2008.09.029","article-title":"Family history of alcohol dependence and initial antidepressant response to an N-methyl-d-aspartate antagonist","volume":"65","author":"Phelps","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib107","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.0013-9580.2004.02204.x","article-title":"Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine","volume":"45","author":"Pisani","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.psychres.2014.10.028_bib108","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.psychres.2013.12.027","article-title":"A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy","volume":"215","author":"Rasmussen","year":"2014","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2014.10.028_bib111","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0269881113478283","article-title":"Serial infusions of low-dose ketamine for major depression","volume":"27","author":"Rasmussen","year":"2013","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib112","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4088\/JCP.12r08046","article-title":"Lamotrigine in psychiatric disorders","volume":"74","author":"Reid","year":"2013","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib113","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1476-5381.1988.tb16552.x","article-title":"Tricyclic antidepressants block N-methyl-d-aspartate receptors: similarities to the action of zinc","volume":"95","author":"Reynolds","year":"1988","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib114","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1176\/appi.ajp.162.2.394","article-title":"Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study","volume":"162","author":"Rowland","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biopsych.2008.08.014","article-title":"Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine","volume":"65","author":"Salvadore","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib116","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/npp.2010.24","article-title":"Anterior cingulate desynchonization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine","volume":"35","author":"Salvadore","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib117","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1017\/S1461145711001593","article-title":"An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression","volume":"15","author":"Salvadore","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib118","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.biopsych.2013.03.032","article-title":"From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders","volume":"73","author":"Sanacora","year":"2013","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib119","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.biopsych.2006.08.037","article-title":"Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms","volume":"61","author":"Sanacora","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib120","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","article-title":"Subtype-specific alterations of \u03b3-aminobutyric acid and glutamate in patients with major depression","volume":"61","author":"Sancora","year":"2004","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib121","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4088\/JCP.09m05659gre","article-title":"Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial","volume":"72","author":"Saricicek","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib122","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/syn.20472","article-title":"Memantine agonist action at dopamine D2 High receptors","volume":"62","author":"Seeman","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.psychres.2014.10.028_bib123","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jcph.122","article-title":"Repeated S-ketamine infusions in therapy resistant depression: a case series","volume":"53","author":"Segmiller","year":"2013","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib124","first-page":"287","article-title":"Relationship of ketamine\u05f3s antidepressant and psychotomimetic effects in unipolar depression","volume":"34","author":"Sos","year":"2013","journal-title":"Neuroendocrinology Letters"},{"key":"10.1016\/j.psychres.2014.10.028_bib125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(98)00580-9","article-title":"Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats","volume":"358","author":"Southam","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib126","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1089\/jpm.2008.9828","article-title":"Intravenous ketamine \u201cburst\u201d for refractory depression in a patient with advanced cancer","volume":"11","author":"Stefanczyk-Sapieha","year":"2008","journal-title":"Journal of Palliative Medicine"},{"key":"10.1016\/j.psychres.2014.10.028_bib127","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.biopsych.2007.04.014","article-title":"Direct inhibitory effect of fluoxetine on N-methyl-d-aspartate receptors in the central nervous system","volume":"62","author":"Szasz","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jad.2012.10.015","article-title":"A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression","volume":"147","author":"Szymkowicz","year":"2013","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.psychres.2014.10.028_bib130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jad.2009.02.022","article-title":"Normal glutamate but elevated myo-inositol in anterior cingulate cortex in recovered depressed patients","volume":"119","author":"Taylor","year":"2009","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.psychres.2014.10.028_bib131","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR\u00b7D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib132","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.4088\/JCP.v69n1211","article-title":"Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features","volume":"69","author":"Trivedi","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"European Journal of Pharmacoology"},{"key":"10.1016\/j.psychres.2014.10.028_bib134","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(71)90153-X","article-title":"Amantadine in depression","volume":"II","author":"Vale","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2014.10.028_bib135","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pscychresns.2010.10.009","article-title":"The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS","volume":"191","author":"Valentine","year":"2011","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2014.10.028_bib136","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib137","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2004.01.019","article-title":"Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes)","volume":"125","author":"Wang","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.psychres.2014.10.028_bib138","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/YCT.0b013e31824d1d02","article-title":"Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder","volume":"28","author":"Wang","year":"2012","journal-title":"Journal of ECT"},{"key":"10.1016\/j.psychres.2014.10.028_bib139","first-page":"844","article-title":"Olfactory bulbectomy and amitriptyline treatment influences mGlu receptors expression in the mouse brain hippocampus","volume":"60","author":"Wieronska","year":"2008","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.psychres.2014.10.028_bib140","first-page":"720","article-title":"Effects of acute serotonin elevation on brain glucose and neurotransmitter metabolism: a 13C MRS study in rats of citalopram administration","volume":"15","author":"Williams","year":"2007","journal-title":"Proceedings of the International Society for Magnetic Resonance in Medicine"},{"key":"10.1016\/j.psychres.2014.10.028_bib141","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-2999(95)00728-8","article-title":"Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at \u03bc-opioid receptors","volume":"297","author":"Wong","year":"1996","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pscychresns.2005.12.004","article-title":"Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis","volume":"147","author":"Yildiz-Yesiloglu","year":"2006","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.psychres.2014.10.028_bib143","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0091-3057(01)00693-1","article-title":"Prolonged effect of an anaesthetic dose of ketamine on behavioral despair","volume":"71","author":"Yilmaz","year":"2002","journal-title":"Pharmacology Biochemistry and Behaviour"},{"key":"10.1016\/j.psychres.2014.10.028_bib144","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/YCT.0b013e3182a4b4c6","article-title":"Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study","volume":"30","author":"Yoosefi","year":"2014","journal-title":"Journal of ECT"},{"key":"10.1016\/j.psychres.2014.10.028_bib145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2012.03.004","article-title":"Relationship of ketamine\u05f3s plasma metabolites with response, diagnosis, and side effects in major depression","volume":"72","author":"Zarate","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib146","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine\u05f3s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib147","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.biopsych.2012.11.031","article-title":"Human biomarkers of rapid antidepressant effects","volume":"73","author":"Zarate","year":"2013","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib148","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1176\/appi.ajp.161.1.171","article-title":"An open-label trial of riluzole in patients with treatment-resistant major depression","volume":"161","author":"Zarate","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib149","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.biopsych.2004.11.023","article-title":"An open-label trial of the glutamate modulating agent riluzole in combination with lithium for the treatment of bipolar depression","volume":"57","author":"Zarate","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib150","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomised trial of N-methyl-d-aspartate antagonist in treatment resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib151","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"Zarate","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2014.10.028_bib152","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R (\u2212)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.psychres.2014.10.028_bib153","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2125.2012.04198.x","article-title":"Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression","volume":"74","author":"Zhao","year":"2012","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.psychres.2014.10.028_bib154","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","article-title":"Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex","volume":"29","author":"Zhou","year":"2014","journal-title":"European Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178114008610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178114008610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:52:11Z","timestamp":1747162331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178114008610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":149,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0165178114008610"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2014.10.028","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine and other potential glutamate antidepressants","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2014.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}